Previous Article in Journal
The Impact of Sodium Glucose Co-Transporter 2 (SGLT-2) Inhibitors on Atherogenesis: A Systematic Review of Experimental and Clinical Evidence
Previous Article in Special Issue
Resveratrol as a Potential Platelet Inhibitor in Aspirin-Resistant Diabetic Patients—A Novel Therapeutic Strategy Targeting F0F1-ATP Synthase Inhibition
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Review

Platelets in Dry Eye Disease: A Narrative Review of Biological Mechanisms and Therapeutic Applications Derived from Platelets

by
Marco Zeppieri
1,2,*,
Caterina Gagliano
3,4,
Alessandro Avitabile
5,
Antonino Maniaci
3,
Francesco Cappellani
3,4,
Riccardo Foti
6,
Giosuè Giordano Incognito
7,
Dalila Incognito
8 and
Roberta Foti
3,9
1
Department of Ophthalmology, University Hospital of Udine, 33100 Udine, Italy
2
Department of Medicine, Surgery and Health Sciences, University of Trieste, 34100 Trieste, Italy
3
Department of Medicine and Surgery, University of Enna “Kore”, 94100 Enna, Italy
4
Eye Center “G.B. Morgagni-DSV”, 95125 Catania, Italy
5
Faculty of Medicine, University of Catania, 95123 Catania, Italy
6
Plastic Surgery, Department of Surgical Sciences, University of Rome “Tor Vergata”, 00133 Rome, Italy
7
Obstetrics and Gynecology Unit, Maternal Child Department, Garibaldi Nesima Hospital, 95100 Catania, Italy
8
Medical Oncology Unit, Department of Human Pathology “G. Barresi”, University of Messina, 98100 Messina, Italy
9
Division of Rheumatology, A.O.U. “Policlinico-San Marco”, 95123 Catania, Italy
*
Author to whom correspondence should be addressed.
Life 2025, 15(11), 1785; https://doi.org/10.3390/life15111785 (registering DOI)
Submission received: 30 September 2025 / Revised: 11 November 2025 / Accepted: 19 November 2025 / Published: 20 November 2025
(This article belongs to the Special Issue The Biology and Functions of Platelets: Emerging Challenges)

Abstract

Background: Platelets have conventionally been viewed as cellular fragments crucial for hemostasis; nonetheless, their extensive secretome of cytokines and growth factors has been increasingly acknowledged as a significant regulator of inflammation and tissue healing at the ocular surface. Aims: The objective of this narrative review is to synthesize existing knowledge of platelet biology with new findings about the therapeutic use of platelet-derived products in dry eye disease (DED). Methods: A qualitative review of the PubMed, Scopus, and Web of Science databases up to June 2025 identified preclinical, translational, and clinical studies assessing platelet-rich plasma (PRP), plasma rich in growth factors (PRGF), platelet lysate, and autologous serum tears for dry eye disease (DED) and associated ocular surface disorders. Results: Platelet-derived formulations have exhibited reliable immunomodulatory and regenerative effects by diminishing inflammatory signaling, lowering cytokine expression, and facilitating epithelial and neurotrophic restoration. Clinical investigations have indicated enhancements in tear film stability, corneal staining, and patient-reported symptoms, especially in cases of moderate-to-severe or refractory illness. Nonetheless, methodological diversity, inconsistent preparation techniques, and restricted sample sizes have impeded comparability among experiments. Conclusions: Platelet-derived treatments constitute a biologically viable and clinically promising strategy for the management of dry eye disease (DED). Future research must emphasize the standardization of preparation protocols, the identification of predictive biomarkers such as transforming growth factor-β1 (TGF-β1), nerve growth factor (NGF), and matrix metalloproteinase-9 (MMP-9), as well as the design of multicenter randomized controlled trials to guarantee reproducible, GMP-compliant clinical applications.
Keywords: platelets; dry eye disease; ocular surface; regeneration; inflammation platelets; dry eye disease; ocular surface; regeneration; inflammation

Share and Cite

MDPI and ACS Style

Zeppieri, M.; Gagliano, C.; Avitabile, A.; Maniaci, A.; Cappellani, F.; Foti, R.; Incognito, G.G.; Incognito, D.; Foti, R. Platelets in Dry Eye Disease: A Narrative Review of Biological Mechanisms and Therapeutic Applications Derived from Platelets. Life 2025, 15, 1785. https://doi.org/10.3390/life15111785

AMA Style

Zeppieri M, Gagliano C, Avitabile A, Maniaci A, Cappellani F, Foti R, Incognito GG, Incognito D, Foti R. Platelets in Dry Eye Disease: A Narrative Review of Biological Mechanisms and Therapeutic Applications Derived from Platelets. Life. 2025; 15(11):1785. https://doi.org/10.3390/life15111785

Chicago/Turabian Style

Zeppieri, Marco, Caterina Gagliano, Alessandro Avitabile, Antonino Maniaci, Francesco Cappellani, Riccardo Foti, Giosuè Giordano Incognito, Dalila Incognito, and Roberta Foti. 2025. "Platelets in Dry Eye Disease: A Narrative Review of Biological Mechanisms and Therapeutic Applications Derived from Platelets" Life 15, no. 11: 1785. https://doi.org/10.3390/life15111785

APA Style

Zeppieri, M., Gagliano, C., Avitabile, A., Maniaci, A., Cappellani, F., Foti, R., Incognito, G. G., Incognito, D., & Foti, R. (2025). Platelets in Dry Eye Disease: A Narrative Review of Biological Mechanisms and Therapeutic Applications Derived from Platelets. Life, 15(11), 1785. https://doi.org/10.3390/life15111785

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop